By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

New IMP building: International research center opens in Vienna

opening ceremony at IMP © IMP

Philipp von Lattorff explains that Boehringer Ingelheim, in its capacity as a family-owned company, has the financial means to support basic research which may first lead to the development of new drugs in the long run. “IMP is the most important investment of Boehringer Ingelheim in basic research”, says the Managing Director of Boehringer Ingelheim RCV.

About IMP

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by the international Boehringer Ingelheim group of companies With over 200 scientists from 40 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms in order to provide detail knowledge of complex biological phenomena. The IMP is a founding member of the Vienna Biocenter, Austria’s beacon in the international elite of top molecular-biological research.

About Boehringer Ingelheim Regional Center Vienna

The Boehringer Ingelheim Regional Center Vienna is responsible for Boehringer Ingelheim’s business with prescription drugs and animal medicines in Austria and over 30 other countries in Central and Eastern Europe, Central Asia, Switzerland and Israel. Moreover, the entire clinical research of the region is managed from Vienna. Vienna is the center for cancer research and also a location for biopharmaceutical research, development and production in the Group. Boehringer Ingelheim is also involved in basic research and is represented in this field by the Research Institute of Molecular Pathology Vienna (IMP). Thus, Boehringer Ingelheim is among Austria’s most research intensive pharmaceutical companies. The Regional Center Vienna generated net sales of EUR 760.2 million in the business year 2015 and employed 3,403 employees in the Central and Eastern European region, 1,501 of whom are in Austria.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us @ Vienna UP'21

    27.4 - 12.5 2021, Vienna, Austria

  • Meet us @ B2B Software-Days 21

    10.05 - 12.05 2021, Online Conference

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Italian flair for Viennese private kitchens

Elena M. Dietz and her partner Giuseppe Di Franca have worked in top international gastronomy for many years and have traveled around the world working.

Speech Recognition Technology from Austria: Philips Speech as a “Hidden Champion”

Speech technology is a growth market. Philips Speech, the global market leader in professional speech to text solutions, is the “Hidden Champion” in this segment, highly active in this area, and has been for decades. Philips supports more than four million customers in 40 countries from its headquarters and production facility in Vienna-Favoriten. On a global basis, Philips Speech employs a staff of 170 people in eight offices, from Atlanta and Brussels to Sydney, and cooperates with more than 1,000 sales and implementation partners.

More news All blog posts